Cancer Drug Resistance
All Journals
Search Log In
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase,
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days
Home Articles Special Issues Volumes Webinars Videos

Cancer Drug Resistance

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Unveiling MAGEA3: a novel predictive biomarker for bevacizumab resistance in colorectal cancer

Juncheng Su, ...Masha Huang,
Open Access Original Article DOI: 10.20517/cdr.2025.35 28 Apr 2025
Views: Downloads:
Download PDF

Ivosidenib enhances cisplatin sensitivity in ovarian cancer by reducing cancer cell stemness

Mengqing Chen, ...Zehua Wang,
Open Access Original Article DOI: 10.20517/cdr.2025.51 24 Apr 2025
Views: Downloads:
Download PDF

Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation

Jinglu Yu, ...Yu Feng,
Open Access Review DOI: 10.20517/cdr.2025.14 24 Apr 2025
Views: Downloads:
Download PDF

The genetic architecture of bone metastases: unveiling the role of epigenetic and genetic modifications in drug resistance

Ahmad Dawalibi, ...Khalid S. Mohammad,
Open Access Review DOI: 10.20517/cdr.2025.28 22 Apr 2025
Views: Downloads:
Download PDF

Mechanisms of resistance to NAMPT inhibitors in cancer

Jansen Redler, ... Christine M. HeskeChristine M. Heske
Open Access Review DOI: 10.20517/cdr.2024.216 15 Apr 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Xiangyu Sun, ... Jianliang Shen
Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

William H. Gmeiner, Charles Chidi Okechukwu
Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Vincenzo SammartanoVincenzo Sammartano, ... Alessandro GozzettiAlessandro Gozzetti
Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF
For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Topic: Ferroptosis, Cuproptosis, and Drug Resistance Research in Cancer
Topic: Papers from the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group
Topic: Tackling the Challenge of Drug Resistance in Lung Cancer
Volume 8 (in progress)
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

The Special Collection "Cancer Cell Plasticity in Therapy Resistance" Officially Launched and Open for Submissions
International Pancreatic Cancer Scientist Prof. Baiyong Shen Joins Cancer Drug Resistance as Associate Editor
We are thrilled to announce that Prof. Baiyong Shen, a globally recognized leader in pancreatic cancer research and Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has officially joined Cancer Drug Resistance as an Associate Editor.
Webinar: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance
The webinar is scheduled for 7th May as an extension of the special issue.
We warmly welcome your participation and contributions.
Empowering Women in Science: Exclusive APC Discount for International Women's Day
This initiative not only recognizes the dedication of women in academia but also demonstrates our commitment to enhancing the participation of female scientists in high-impact research.
Women Scientists Driving Cancer Research: Articles from 2023-2024
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.
Announcement: Cancer Drug Resistance Best Paper Awards
Authors of Review and Research Articles published in 2023-2024 have a chance to win the Best Paper Award, celebrating groundbreaking contributions to the field of cancer drug resistance.

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Xiangyu Sun, ... Jianliang Shen
Open Access | Review | 19 Jun 2023
Views: | Downloads:
Download PDF
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects
William H. Gmeiner, Charles Chidi Okechukwu
Open Access | Review | 28 Apr 2023
Views: | Downloads:
Download PDF
Anti-BCMA novel therapies for multiple myeloma
Vincenzo SammartanoVincenzo Sammartano, ... Alessandro GozzettiAlessandro Gozzetti
Open Access | Review | 21 Mar 2023
Views: | Downloads:
Download PDF
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties